ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677169 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677169; 2) Community: the network communities that were significantly associated with the response to NSC 677169; 3) Molecule: the relationships between components within communities and NSC 677169; 4) MDR: the compounds that were significantly associated with the NSC 677169.

NSC Compound Enrichment Correlation
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.049093561024907 0.30652405
NSC 753188 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.049093561024907 -0.13589503
NSC 758617 Atorvastatin calcium (USAN) 0.049093561024907 -0.0054655836
NSC 762611 Null 0.049093561024907 0.13041319
NSC 708416 Null 1.2187791866317e-005 0.43406243
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 1.49667137663235e-005 0.47863805
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 1.49667137663235e-005 0.52019863
NSC 711618 Null 1.49667137663235e-005 0.43189031
NSC 254681 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) 3.25006101781776e-005 0.59802258
NSC 618939 Camptothecin Derivative 3.40252996142932e-005 0.52604166
Total:95  Current:94    [First] [Prev] [Next] [Last]